Global Information
회사소개 | 문의 | 비교리스트

세계의 동물용 의약품 시장 : 제품 종류별 , 제품별(외부구충제, 내부구충제, 항염증제, 기관지확장제), 동물 종류별, 등록별, 지역별 예측과 기회

Global Animal Pharmaceuticals Market By Product Type, By Product (Ectoparasiticides, Endoparasiticides, Anti-Inflammatories, Bronchodilators ), By Animal Type, By Registration, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934730
페이지 정보 영문 114 Pages
가격
US $ 4,450 ₩ 5,070,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,209,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,767,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 동물용 의약품 시장 : 제품 종류별 , 제품별(외부구충제, 내부구충제, 항염증제, 기관지확장제), 동물 종류별, 등록별, 지역별 예측과 기회 Global Animal Pharmaceuticals Market By Product Type, By Product (Ectoparasiticides, Endoparasiticides, Anti-Inflammatories, Bronchodilators ), By Animal Type, By Registration, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 114 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

동물용 의약품 시장은 반려동물용과 산업동물용으로 분류되며, 반려동물용 시장이 큰 점유율을 차지하고 있습니다. 최대 시장은 축산이 번성하고 반려동물 사육수도 많은 북미 지역이며, 아시아태평양 시장도 빠르게 성장하고 있습니다. 각국 정부의 동물 실험에 관한 규제 강화, e-commerce 플랫폼을 통해 판매되는 위조 의약품 문제 등 성장을 저해하는 요인은 있지만, 시장은 2025년까지 꾸준히 성장할 전망입니다.

세계의 동물용 의약품(Animal Pharmaceuticals) 시장을 조사했으며, 각 지역 시장 전망, 시장 역학과 동향, 경쟁 상황과 주요 기업 개요 등의 정보와 함께 전략적 제안도 제시하고 있습니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계 시장 전망

  • 시장 규모와 예측
    • 금액 기준과 수량 기준
  • 시장 점유율과 예측
    • 제품 종류별(백신, 수의용 의약품, 기타)
    • 제품별
    • 동물 종류별(반려동물, 산업동물)
    • 등록별(제네릭 의약품, 특허 의약품)
    • 지역별(아시아태평양, 유럽, 북미, 남미, 중동 및 아프리카)
    • 기업별(2019년)
  • 제품 시장 맵

제6장 아시아태평양 시장 전망

  • 시장 규모와 예측
    • 금액 기준과 수량 기준
  • 시장 점유율과 예측
    • 제품 종류별
    • 제품별
    • 동물 종류별
    • 국가별
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제7장 유럽 시장 전망

  • 시장 규모와 예측
    • 금액 기준과 수량 기준
  • 시장 점유율과 예측
    • 제품 종류별
    • 제품별
    • 동물 종류별
    • 국가별
  • 유럽 : 국가별 분석
    • 영국
    • 이탈리아
    • 프랑스
    • 독일
    • 스페인

제8장 북미 시장 전망

  • 시장 규모와 예측
    • 금액 기준과 수량 기준
  • 시장 점유율과 예측
    • 제품 종류별
    • 제품별
    • 동물 종류별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제9장 남미 시장 전망

  • 시장 규모와 예측
    • 금액 기준과 수량 기준
  • 시장 점유율과 예측
    • 제품 종류별
    • 제품별
    • 동물 종류별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카 시장 전망

  • 시장 규모와 예측
    • 금액 기준과 수량 기준
  • 시장 점유율과 예측
    • 제품 종류별
    • 제품별
    • 동물 종류별
    • 국가별
  • 중동 및 아프리카 : 국가별 분석
    • UAE
    • 사우디아라비아
    • 카타르
    • 남아프리카공화국

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향

제13장 가격 분석

제14장 특허/FDA 승인에 관한 분석

  • 신제품 개발(승인 신청 상황)
  • 기업별
  • 등록일
  • 특허 기한 만료

제15장 경쟁 상황

  • 주요 기업 개요
    • Zoetis Inc
    • Merck Animal Health
    • Vetoquinol SA
    • Zoetis Inc
    • Virbac SA
    • Boehringer Ingelheim International GmbH
    • Eli Lilly & Co
    • Perrigo Co PLC
    • Sanofi SA
    • Bayer AG
    • Elanco Animal Health Inc
    • Ceva Sante Animale S.A.
    • Covetrus Inc.
    • Idexx Laboratories Inc.
    • Vetoquinol USA, Inc.
    • Norbrook Laboratories, Ltd.
    • Huvepharma EOOD
    • Adivo GmbH
    • Ceva Sant Animale
    • Phibro Animal Health Corp.

제16장 전략적 제안

제17장 면책사항

KSM 20.05.18

The market for animal pharmaceuticals market is likely to grow with a steady CAGR during the forecast period due to the increase in pet adoption, rise in fatal diseases like Ebola and swine flu spreading from consumption of dairy and animal related products. Animal pharmaceuticals are highly beneficial in diagnosis and treatment of animal disorders. The restraining factors for the market can be the government rules regarding animal testing, and the probability of sales of fake medicines across e-commerce platforms.

The global animal pharmaceuticals market is segmented on the basis of product type, product, animal type, registration and region. Based on animal type, the market is segmented into companion and production animals. Companion animals tend to hold a larger share in the market as pet owners are concerned for their pet's health and well-being. As compared to production animals, companion animals receive special care and veterinary treatment from their owners, which is the major factor driving the market share of this segment.

The overall animal pharmaceuticals market is widespread, expanding itself to Asia-Pacific, Europe, North America, South America, and Middle East & Africa. North America holds the largest market share by virtue of the pre-existing established pharmaceutical companies and the increasing consumption of meat and milk in the region. However, fastest growth is shown by the Asia-Pacific sector due to export of animals to other countries. Export process involves testing of the animals with which farm owners need to comply with therefore, the region is expected to witness highest growth over the next five years.

Major players of the animal pharmaceuticals market include Zoetis Inc, Merck Animal Health, Vetoquinol SA, Zoetis Inc, Virbac SA, Boehringer Ingelheim International GmbH, Eli Lilly & Co, Perrigo Co PLC, Sanofi SA, Bayer AG, Elanco Animal Health Inc, Ceva Sante Animale S.A., Covetrus Inc., Idexx Laboratories Inc., Vetoquinol USA, Inc., Norbrook Laboratories, Ltd., Huvepharma EOOD, Adivo GmbH, Ceva Sant Animale, Phibro Animal Health Corp, etc. The inter-company competition keeps on increasing parallelly with the market which in turn leads to innovations in technology, thus enhancing animal healthcare sector.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global animal pharmaceuticals market.
  • To classify and forecast global animal pharmaceuticals market based on product type, product, animal type, registration and region.
  • To identify drivers and challenges for global animal pharmaceuticals market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global animal pharmaceuticals market.
  • To conduct pricing analysis for global animal pharmaceuticals market.
  • To identify and analyze the profile of leading players operating in global animal pharmaceuticals market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global animal pharmaceuticals market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Manufacturers, suppliers of medicines, distributors and other stakeholders
  • Animal healthcare centers, vets
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to animal pharmaceuticals
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global animal pharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Product Type:

Vaccine

Veterinary

Others

  • Market, By Product:

Ectoparasiticides

  • Ivermectin
  • Cypermethrin
  • Fipronil
  • Coumaphos
  • Others

Endoparasiticides

  • Ivermectin
  • Praziquantel
  • Flubendazol
  • Milbemycin
  • Levamisole
  • Fenbendazole
  • Pyrantel
  • Others

Anti-Inflammatories

  • NSAIDs
  • Corticosteroids
  • Others

Bronchodilators

  • Theophylline
  • Albuterol
  • Others
  • Market, By Animal Type:

Companion Animals

Production Animals

  • Market, By Registration:

Generic

Patented

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Europe

  • United Kingdom
  • Italy
  • France
  • Germany
  • Spain

North America

  • United States
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global animal pharmaceuticals market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customers

5. Global Animal Pharmaceuticals Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Vaccine, Veterinary, Others)
    • 5.2.2. By Product
      • 5.2.2.1. Ectoparasiticides (Ivermectin, Cypermethrin, Fipronil, Coumaphos, Others)
      • 5.2.2.2. Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin, Levamisole, Fenbendazole, Pyrantel, Others)
      • 5.2.2.3. Anti-Inflammatories (NSAIDs, Corticosteroids, Others)
      • 5.2.2.4. Bronchodilators (Theophylline, Albuterol, Others)
    • 5.2.3. By Animal Type (Companion Animals, Production Animals)
    • 5.2.4. By Registration (Generic, Patented)
    • 5.2.5. By Region (Asia-Pacific, Europe, North America, South America, MEA)
    • 5.2.6. By Company (2019)
  • 5.3. Product Market Map

6. Asia-Pacific Animal Pharmaceuticals Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Product
    • 6.2.3. By Animal Type
    • 6.2.4. By Country (China; India; Japan; South Korea; Australia)
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Animal Pharmaceuticals Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Animal Type
    • 6.3.2. India Animal Pharmaceuticals Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Animal Type
    • 6.3.3. Japan Animal Pharmaceuticals Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Animal Type
    • 6.3.4. South Korea Animal Pharmaceuticals Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value & Volume
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product Type
        • 6.3.4.2.2. By Product
        • 6.3.4.2.3. By Animal Type
    • 6.3.5. Australia Animal Pharmaceuticals Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value & Volume
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product Type
        • 6.3.5.2.2. By Product
        • 6.3.5.2.3. By Animal Type

7. Europe Animal Pharmaceuticals Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Product
    • 7.2.3. By Animal Type
    • 7.2.4. By Country (United Kingdom; Italy; France; Germany; Spain)
  • 7.3. Europe: Country Analysis
    • 7.3.1. United Kingdom Animal Pharmaceuticals Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Animal Type
    • 7.3.2. Italy Animal Pharmaceuticals Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Animal Type
    • 7.3.3. France Animal Pharmaceuticals Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Animal Type
    • 7.3.4. Germany Animal Pharmaceuticals Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Animal Type
    • 7.3.5. Spain Animal Pharmaceuticals Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Animal Type

8. North America Animal Pharmaceuticals Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Product
    • 8.2.3. By Animal Type
    • 8.2.4. By Country (United States, Canada, Mexico)
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Animal Pharmaceuticals Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Animal Type
    • 8.3.2. Canada Animal Pharmaceuticals Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Animal Type
    • 8.3.3. Mexico Animal Pharmaceuticals Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Animal Type

9. South America Animal Pharmaceuticals Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Product
    • 9.2.3. By Animal Type
    • 9.2.4. By Country (Brazil, Argentina, Colombia)
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Animal Pharmaceuticals Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Animal Type
    • 9.3.2. Argentina Animal Pharmaceuticals Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Animal Type
    • 9.3.3. Colombia Animal Pharmaceuticals Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Animal Type

10. Middle East and Africa (MEA) Animal Pharmaceuticals Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Product
    • 10.2.3. By Animal Type
    • 10.2.4. By Country (UAE; Saudi Arabia; Qatar, South Africa)
  • 10.3. Middle East and Africa (MEA): Country Analysis
    • 10.3.1. UAE Animal Pharmaceuticals Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Animal Type
    • 10.3.2. Saudi Arabia Animal Pharmaceuticals Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Animal Type
    • 10.3.3. Qatar Animal Pharmaceuticals Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Animal Type
    • 10.3.4. South Africa Animal Pharmaceuticals Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value & Volume
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product Type
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Animal Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Pricing Analysis

14. Patent / FDA Approval Analysis

  • 14.1. New Product Development (NADA, ANADA, CNADA)
  • 14.2. By Company
  • 14.3. Registration Date
  • 14.4. Patent Expiry

15. Competitive Landscape

  • 15.1. Company Profiles (Leading Companies)
    • 15.1.1. Zoetis Inc
    • 15.1.2. Merck Animal Health
    • 15.1.3. Vetoquinol SA
    • 15.1.4. Zoetis Inc
    • 15.1.5. Virbac SA
    • 15.1.6. Boehringer Ingelheim International GmbH
    • 15.1.7. Eli Lilly & Co
    • 15.1.8. Perrigo Co PLC
    • 15.1.9. Sanofi SA
    • 15.1.10. Bayer AG
    • 15.1.11. Elanco Animal Health Inc
    • 15.1.12. Ceva Sante Animale S.A.
    • 15.1.13. Covetrus Inc.
    • 15.1.14. Idexx Laboratories Inc.
    • 15.1.15. Vetoquinol USA, Inc.
    • 15.1.16. Norbrook Laboratories, Ltd.
    • 15.1.17. Huvepharma EOOD
    • 15.1.18. Adivo GmbH
    • 15.1.19. Ceva Sant Animale
    • 15.1.20. Phibro Animal Health Corp.

16. Strategic Recommendations

17. About Us & Disclaimer

Back to Top
전화 문의
F A Q